The rate of immune escape vanishes when multiple immune responses control an HIV infection

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 3277-3286

  Van Deutekom, Hanneke W M ^a   Wijnker, Gilles ^a   De Boer, Rob J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE ESCAPE; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION RATE; MATHEMATICAL MODEL; MUTATION RATE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS MUTATION;

HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; MODELS, THEORETICAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84884217651     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300962     Document Type: Article

References (56)

1. Little, S. J., A. R. McLean, C. A. Spina, D. D. Richman, and D. V. Havlir. 1999. Viral dynamics of acute HIV-1 infection. J. Exp. Med. 190: 841-850.
2. Phillips, A. N. 1996. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271: 497-499.
3. Schmitz, J. E., M. J. Kuroda, S. Santra, V. G. Sasseville, M. A. Simon, M. A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. J. Scallon, et al. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
4. Regoes, R. R., R. Antia, D. A. Garber, G. Silvestri, M. B. Feinberg, and S. I. Staprans. 2004. Roles of target cells and virus-specific cellular immunity in primary simian immunodeficiency virus infection. J. Virol. 78: 4866-4875.
5. Allen, T. M., M. Altfeld, S. C. Geer, E. T. Kalife, C. Moore, K. M. O'Sullivan, I. Desouza, M. E. Feeney, R. L. Eldridge, E. L. Maier, et al. 2005. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 79: 13239-13249.
6. Goonetilleke, N., M. K. P. Liu, J. F. Salazar-Gonzalez, G. Ferrari, E. Giorgi, V. V. Ganusov, B. F. Keele, G. H. Learn, E. L. Turnbull, M. G. Salazar, et al.; CHAVI Clinical Core B. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206: 1253-1272.
7. Hedskog, C., M. Mild, J. Jernberg, E. Sherwood, G. Bratt, T. Leitner, J. Lundeberg, B. Andersson, and J. Albert. 2010. Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLoS One 5: e11345.
8. Bimber, B. N., B. J. Burwitz, S. O'Connor, A. Detmer, E. Gostick, S. M. Lank, D. A. Price, A. Hughes, and D. O'Connor. 2009. Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J. Virol. 83: 8247-8253.
9. Fischer, W., V. V. Ganusov, E. E. Giorgi, P. T. Hraber, B. F. Keele, T. Leitner, C. S. Han, C. D. Gleasner, L. Green, C.-C. Lo, et al. 2010. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 5: e12303.
10. Henn, M. R., C. L. Boutwell, P. Charlebois, N. J. Lennon, K. A. Power, A. R. Macalalad, A. M. Berlin, C. M. Malboeuf, E. M. Ryan, S. Gnerre, et al. 2012. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 8: e1002529.
11. Liu, M. K., N. Hawkins, A. J. Ritchie, V. V. Ganusov, V. Whale, S. Brackenridge, H. Li, J. W. Pavlicek, F. Cai, M. Rose-Abrahams, et al.; CHAVI Core B. 2013. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J. Clin. Invest. 123: 380-393.
12. Asquith, B., C. T. T. Edwards, M. Lipsitch, and A. R. McLean. 2006. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 4: e90.
13. Ganusov, V. V., N. Goonetilleke, M. K. P. Liu, G. Ferrari, G. M. Shaw, A. J. McMichael, P. Borrow, B. T. Korber, and A. S. Perelson. 2011. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. J. Virol. 85: 10518-10528.
14. Koibuchi, T., T. M. Allen, M. Lichterfeld, S. K. Mui, K. M. O'Sullivan, A. Trocha, S. A. Kalams, R. P. Johnson, and B. D. Walker. 2005. Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection. J. Virol. 79: 8171-8181.
15. Draenert, R., C. L. Verrill, Y. Tang, T. M. Allen, A. G. Wurcel, M. Boczanowski, A. Lechner, A. Y. Kim, T. Suscovich, N. V. Brown, et al. 2004. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J. Virol. 78: 630-641.
16. Goulder, P. J., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, et al. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3: 212-217.
17. Althaus, C. L., and R. J. De Boer. 2008. Dynamics of immune escape during HIV/SIV infection. PLOS Comput. Biol. 4: e1000103.
18. De Boer, R. J. 2007. Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus. J. Virol. 81: 2838-2848.
19. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126.
20. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
21. Klenerman, P., R. E. Phillips, C. R. Rinaldo, L. M. Wahl, G. Ogg, R. M. May, A. J. McMichael, and M. A. Nowak. 1996. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc. Natl. Acad. Sci. USA 93: 15323-15328.
22. Althaus, C. L., and R. J. De Boer. 2011. Implications of CTL-mediated killing of HIV-infected cells during the non-productive stage of infection. PLoS One 6: e16468.
23. Klatt, N. R., E. Shudo, A. M. Ortiz, J. C. Engram, M. Paiardini, B. Lawson, M. D. Miller, J. Else, I. Pandrea, J. D. Estes, et al. 2010. CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog. 6: e1000747.
24. Wong, J. K., M. C. Strain, R. Porrata, E. Reay, S. Sankaran-Walters, C. C. Ignacio, T. Russell, S. K. Pillai, D. J. Looney, and S. Dandekar. 2010. In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog. 6: e1000748.
25. Ramratnam, B., S. Bonhoeffer, J. Binley, A. Hurley, L. Zhang, J. E. Mittler, M. Markowitz, J. P. Moore, A. S. Perelson, and D. D. Ho. 1999. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354: 1782-1785.
26. De Boer, R. J., R. M. Ribeiro, and A. S. Perelson. 2010. Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues. PLOS Comput. Biol. 6: e1000906.
27. De Boer, R. J., and A. S. Perelson. 1995. Towards a general function describing T cell proliferation. J. Theor. Biol. 175: 567-576.
28. Borghans, J. A., R. J. de Boer, and L. A. Segel. 1996. Extending the quasi-steady state approximation by changing variables. Bull. Math. Biol. 58: 43-63.
29. Balagam, R., V. Singh, A. R. Sagi, and N. M. Dixit. 2011. Taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of HIV-1. PLoS One 6: e14531.
30. Seo, T.-K., J. L. Thorne, M. Hasegawa, and H. Kishino. 2002. Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. Genetics 160: 1283-1293.
31. Liu, Y., and J. E. Mittler. 2008. Selection dramatically reduces effective population size in HIV-1 infection. BMC Evol. Biol. 8: 133.
32. Calis, J. J. A., R. J. de Boer, and C. Keşmir. 2012. Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire. PLOS Comput. Biol. 8: e1002412.
33. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69: 5087-5094.
34. De Boer, R. J. 2012. Which of our modeling predictions are robust? PLOS Comput. Biol. 8: e1002593.
35. Liu, Y., J. P. McNevin, S. Holte, M. J. McElrath, and J. I. Mullins. 2011. Dynamics of viral evolution and CTL responses in HIV-1 infection. PLoS One 6: e15639.
36. Mandl, J. N., R. R. Regoes, D. A. Garber, and M. B. Feinberg. 2007. Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape. J. Virol. 81: 11982-11991.
37. Chopera, D. R., M. Mlotshwa, Z. Woodman, K. Mlisana, D. de Assis Rosa, D. P. Martin, S. Abdool Karim, C. M. Gray, and C. Williamson; CAPRISA 002 Study Team. 2011. Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals. J. Virol. 85: 7070-7080.
38. Matthews, P. C., J. Listgarten, J. M. Carlson, R. Payne, K.-H. G. Huang, J. Frater, D. Goedhals, D. Steyn, C. van Vuuren, P. Paioni, et al. 2012. Co-operative additive effects between HLA alleles in control of HIV-1. PLoS One 7: e47799.
39. Mothe, B., J. Ibarrondo, A. Llano, and C. Brander. 2009. Virological, immune and host genetics markers in the control of HIV infection. Dis. Markers 27: 105-120.
40. Martinez-Picado, J., J. G. Prado, E. E. Fry, K. Pfafferott, A. Leslie, S. Chetty, C. Thobakgale, I. Honeyborne, H. Crawford, P. Matthews, et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80: 3617-3623.
41. Huang, K.-H. G., D. Goedhals, J. M. Carlson, M. A. Brockman, S. Mishra, Z. L. Brumme, S. Hickling, C. S. W. Tang, T. Miura, C. Seebregts, et al.; Bloemfontein-Oxford Collaborative Group. 2011. Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations. PLoS One 6: e19018.
42. Noviello, C. M., C. S. López, B. Kukull, H. McNett, A. Still, J. Eccles, R. Sloan, and E. Barklis. 2011. Second-site compensatory mutations of HIV-1 capsid mutations. J. Virol. 85: 4730-4738.
43. Brockman, M. A., A. Schneidewind, M. Lahaie, A. Schmidt, T. Miura, I. Desouza, F. Ryvkin, C. A. Derdeyn, S. Allen, E. Hunter, et al. 2007. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 81: 12608-12618.
44. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Köppe, K. Sigmund, C. R. Bangham, et al. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375: 606-611.
45. Kadolsky, U. D., and B. Asquith. 2010. Quantifying the impact of human immunodeficiency virus-1 escape from cytotoxic T-lymphocytes. PLOS Comput. Biol. 6: e1000981.
46. Miura, T., Z. L. Brumme, M. A. Brockman, P. Rosato, J. Sela, C. J. Brumme, F. Pereyra, D. E. Kaufmann, A. Trocha, B. L. Block, et al. 2010. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J. Virol. 84: 7581-7591.
47. Chopera, D. R., Z. Woodman, K. Mlisana, M. Mlotshwa, D. P. Martin, C. Seoighe, F. Treurnicht, D. A. de Rosa, W. Hide, S. A. Karim, et al.; CAPRISA 002 Study Team. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog. 4: e1000033.
48. Crawford, H., J. G. Prado, A. Leslie, S. Hué, I. Honeyborne, S. Reddy, M. van der Stok, Z. Mncube, C. Brander, C. Rousseau, et al. 2007. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 81: 8346-8351.
49. Fryer, H. R., J. Frater, A. Duda, M. G. Roberts, R. E. Phillips, and A. R. McLean; SPARTAC Trial Investigators. 2010. Modelling the evolution and spread of HIV immune escape mutants. PLoS Pathog. 6: e1001196.
50. Grijsen, M. L., R. Steingrover, F. W. N. M. Wit, S. Jurriaans, A. Verbon, K. Brinkman, M. E. van der Ende, R. Soetekouw, F. de Wolf, J. M. A. Lange, et al.; Primo-SHM Study Group. 2012. No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. PLoS Med. 9: e1001196.
51. Rosenberg, E. S., M. Altfeld, S. H. Poon, M. N. Phillips, B. M. Wilkes, R. L. Eldridge, G. K. Robbins, R. T. D'Aquila, P. J. Goulder, and B. D. Walker. 2000. Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
52. Steingrover, R., E. F. Garcia, I. G. M. van Valkengoed, V. Bekker, D. Bezemer, F. P. Kroon, L. Dekker, M. Prins, F. de Wolf, J. M. A. Lange, and J. M. Prins. 2010. Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection. AIDS Res. Hum. Retroviruses 26: 379-387.
53. Sáez-Cirión, A., C. Bacchus, L. Hocqueloux, V. Avettand-Fenoel, I. Girault, C. Lecuroux, V. Potard, P. Versmisse, A. Melard, T. Prazuck, et al.; ANRS VISCONTI Study Group. 2013. Post-treatment HIV-1 controllers with a longterm virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 9: e1003211.
54. Mattapallil, J. J., D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
55. Dixit, N. M., M. Markowitz, D. D. Ho, and A. S. Perelson. 2004. Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy. Antivir. Ther. 9: 237-246.
56. Davenport, M. P., R. M. Ribeiro, and A. S. Perelson. 2004. Kinetics of virusspecific CD8+ T cells and the control of human immunodeficiency virus infection. J. Virol. 78: 10096-10103.